Viewing StudyNCT01874288



Ignite Creation Date: 2024-05-06 @ 1:42 AM
Last Modification Date: 2024-10-26 @ 11:08 AM
Study NCT ID: NCT01874288
Status: TERMINATED
Last Update Posted: 2020-11-24
First Post: 2013-06-07

Brief Title: A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL
Sponsor: Alopexx Oncology LLC
Organization: Alopexx Oncology LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-11-25
Start Date Type: ACTUAL
Primary Completion Date: 2014-01-27
Primary Completion Date Type: ACTUAL
Completion Date: 2016-11-16
Completion Date Type: ACTUAL
First Submit Date: 2013-06-07
First Submit QC Date: June 10 2013
Study First Post Date: 2013-06-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-11-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-02
Last Update Post Date: 2020-11-24
Last Update Post Date Type: ACTUAL